Zdrowie i gospodarka · 09/12/2020
FDA Releases Draft Guidance on Best Practices for Proprietary Names of Human Nonprescription Drugs
The FDA is releasing a draft guidance to help pharmaceutical companies develop proprietary names for human nonprescription drugs, aiming to minimize medication errors and avoid names that may violate the FD&C Act.
Source: Federal Register — Food and Drug AdministrationOpen original release →